The data are in: Corporate wellness programs work

Corporate wellness programs can return as high as $3 for every $1 invested, as they are linked to reduced healthcare costs, increased productivity, decreased absenteeism and higher job satisfaction, according to a Huffington Post blog.  

Knowing what to measure to prove these programs’ positive ROI is an important aspect of launching a wellness program.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.